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COMMENTARY
Detecting senescence: a new method for an old pigment
Hanna Salmonowicz and Jo~ao F. Passos
Institute for Cell and Molecular Biosciences & Newcastle University Institute
for Ageing, Newcastle upon Tyne NE4 5PL, UK
Summary
Cellular senescence is a state of irreversible cell cycle arrest
induced by different types of cellular stresses. The field of
senescence has made significant advances in the understanding
of many of the mechanisms governing this phenomenon; how-
ever, a universal biomarker that unambiguously distinguishes
senescent from proliferating cells has not been found. In this
issue of Aging Cell, Evangelou and colleagues developed a
sensitive method for identification of senescent cells in different
types of biological material based on the detection of lipofuscin
using an analogue of Sudan Black B (SBB) histochemical dye
coupled with biotin, which they named GL13. The authors
propose that this method is more sensitive and versatile than
using SBB alone. Lipofuscin, a nondegradable oxidation product
of lipids, proteins and metals, is found in senescent cells.
Detection of lipofuscin using GL13 staining may be a more
feasible method than others currently used for identification of
senescent cells both in cell culture and tissues.
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Introduction
Cellular senescence has been defined as an irreversible cell cycle arrest
which stops the propagation of damaged cells. It was first observed by
Hayflick and Moorhead who demonstrated a limited replicative lifespan
of human fibroblasts in culture (Hayflick & Moorhead, 1961).
Several stressors such as the shortening of telomeres, DNA lesions,
oncogene activation, oxidative stress and others can induce cellular
senescence (van Deursen, 2014). Depending on the trigger, senescence
can be executed by several different effector pathways. The major ones
comprise the p53-p21 and p16 pathways. Senescent cells experience
dramatic changes at the level of gene expression, mitochondrial function
(Correia-Melo et al., 2016) and epigenome (Cruickshanks et al., 2013).
Furthermore, senescent cells have been shown to have a distinct
secretome profile, known as senescence-associated secretory phenotype
(SASP) (Coppe et al., 2008). SASP includes growth factors, extracellular
matrix degrading proteins and pro-inflammatory cytokines. Through the
SASP, senescent cells communicate with the immune system to
orchestrate their own clearance and stimulate local progenitor cells to
regenerate the tissue (van Deursen, 2014). However, the SASP is also
capable of inducing senescence in adjacent, healthy cells, thereby
contributing to tissue degeneration (Acosta et al., 2013). Impairment of
clearance of senescent cells and chronic exposure to the SASP may result
in the accumulation of senescent cells and paradoxically promote
tumorigenesis.
The challenge of identifying a universal marker of
senescence
Senescent cells have been recently shown to contribute causally to the
aging process. Elimination of senescent cells by suicide gene-meditated
ablation of p16Ink4a-expressing senescent cells in INK-ATTAC mice has
led to improvements in healthspan and lifespan suggesting that
senescent cells are drivers of aging (Baker et al., 2016). This has
prompted the scientific community to identify new interventions to
target senescence as a therapy against aging and age-related diseases
(Zhu et al., 2015). However, despite remarkable advances, the detection
of senescent cells, particularly in tissues, is still a major challenge.
There are several reasons, both of a biological and methodological
nature, which have hindered the identification of specific markers able to
determine whether a cell is senescent or not:
Firstly, while senescence is characterized by numerous changes in
gene expression, very few of these differences are exclusive to senescent
cells. Secondly, senescence is a kinetic, multifactorial process, with
several phenotypic changes occurring at different time points following
the initial cell cycle arrest. This could explain why aged tissues are highly
heterogeneous, possibly containing cells at different stages of the
senescent programme. Thirdly, senescent cells manifest the phenotype
differently depending on the type of inducing stimuli or the cell type (van
Deursen, 2014). Finally, recent data have highlighted that senescence
may play different physiological roles in different contexts. For instance,
an ‘acute’ type of senescence has been shown to play a beneficial role
during processes such as development or tissue repair (Mu~noz-Espın
et al., 2013; Demaria et al., 2014), while a ‘chronic’ type of senescence
may contribute to aging and age-related disease. The recent realization
that there may be different types of senescent cells in tissues has created
an additional obstacle to the identification of a universal marker.
The detection of senescence-associated b-galactosidase (SA-b-Gal)
activity at pH 6 is probably the most widely utilized method for
identification of senescent cells (Dimri et al., 1995). Nevertheless, there
are major limitations to this method. SA b-Gal staining may occur in
quiescent cells induced by confluency or serum starvation and in
immortalized cells (Cristofalo, 2005). Furthermore, this method requires
fresh, nonfixed material, which limits its applicability and the use of
archived material. Its detection in tissues is technically challenging and
has generated contradictory results. Given the growing realization that
senescence is a multifactorial process, a multimarker approach is being
favoured by many researchers in the field.
Examples of currently used markers are as follows: increased
expression of cyclin kinase inhibitors p21 and p16 and absence of
proliferation markers; telomere-associated DNA damage foci (Hewitt
et al., 2012); senescence-associated heterochromatin foci (SAHF; Narita
et al., 2003); loss of lamin B1 (Shimi et al., 2011); senescence-associated
distension of satellites (SADS) (Swanson et al., 2013); and expression of
components of the SASP (Coppe et al., 2008) amongst several others.
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Nonetheless, there is also growing realization that many of these
markers are not exclusive to all types of senescence and may only occur
in specific cell types.
Detection of lipofuscin as a senescent marker
Lipofuscin is a nondegradable aggregate of oxidized lipids, covalently
cross-linked proteins, oligosaccharides and transition metals which
accumulate within lysosomes. It is a product of iron-catalysed oxidation
and polymerization reactions of a variety of cellular structures and
macromolecules (Terman & Brunk, 2004). Its discovery is credited to
Hannover in 1842. Multiple studies indicate that lipofuscin accumulates
in various tissues and species with age, particularly postmitotic tissues
such as the brain and cardiac and skeletal muscle (Terman & Brunk,
2004). However, lipofuscin has also been shown to accumulate during
replicative senescence of human fibroblasts (von Zglinicki et al., 1995).
Lipofuscin is autofluorescent and can be visualized using fluorescent
microscopy; however, several other histochemical methods have been
described based on lipid detection, such as staining using Sudan Black B
(SBB) amongst others.
In this article, Evangekou and colleagues designed and synthesized a
structurally similar compound to SBB and coupled it to biotin. Commer-
cially available SBB contain numerous impurities which impact on
staining quality and justified the need to synthesize a new analogue. The
chemical coupling with biotin allows its detection using antibiotin
antibodies and thereby increases its detection sensitivity (Fig. 1). The
authors show evidence for the versatility of this method: it can be
detected in fresh, frozen cells and tissues, but also in fixed material.
Furthermore, it can be identified in cells using both microscopy and flow
cytometry. Their data indicate that GL13 staining can overcome some of
the limitations of the standard SBB staining. SBB staining is less
pronounced and requires a higher magnification.
The authors present multiple examples of positively stained cultured
cells induced to senescence by replicative exhaustion, genotoxic stress,
overexpression of p21 or oncogene activation. Furthermore, they reveal
that mouse models of cellular senescence and human clinical samples of
malignant lesions and irradiated tissue are characterized by elevated
numbers of GL13-positive cells, when compared to controls.
Despite its obvious advantages, users should be aware of some
possible limitations of the method. For instance, lysosomes may be
loaded with degradable material, described as ‘temporary lipofuscin’,
but also lipid droplets and glycogen which may be detected by methods
such as SBB (Terman & Brunk, 2004). It is therefore plausible that ‘false
positives’ may be detected using this method.
In addition, age-dependent accumulation of lipofuscin has been
shown to occur in postmitotic tissues which in theory should not
experience the phenotype originally described by Hayflick. This is at odds
with the idea that lipofuscin accumulation is specific to senescent cells.
One explanation is that similar pathways which drive senescence in
mitotic cells can also be activated in postmitotic cells, as demonstrated in
neurons (Jurk et al., 2012) and adipocytes (Minamino et al., 2009).
Whether detection of lipofuscin overlaps with other senescent markers
in postmitotic tissues warrants further investigation.
While the authors have convincingly demonstrated that lipofuscin
accumulation correlates with senescent markers in cell culture and that
lipofuscin increases in tissues with age, future work should investigate
more thoroughly whether and to what extent the lipofuscin signal
overlaps with other established senescent markers such as SA-b-Gal or
p16 expression during aging in vivo. Finally, strategies such as the
recently developed mouse models where p16-expressing senescent cells
can be specifically eliminated (Demaria et al., 2014; Baker et al., 2016)
could be applied to further ascertain the specificity of this method.
A separate question which arises from this work is whether lipofuscin
accumulation is a mere consequence of the induction of the senescence
programme or whether its accumulation contributes causally to the
development of senescence. The latter hypothesis would be consistent
with early findings which demonstrated that synthetic lipofuscin could
induce senescence in human fibroblasts (von Zglinicki et al., 1995).
The last decade has seen incredible advances in the field of cellular
senescence with the realization that senescent cells play important,
albeit distinct, roles in vivo. However, one major challenge for the
community is the identification of specific markers. The novel method
proposed by Evangelou and colleagues offers a possible easy and
versatile solution, but whether it works as a standalone marker or should
be used in combination with several others remains to be determined.
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Fig. 1 Strategy employed by Evangelou
and colleagues to develop a new marker of
senescence based on detection of
lipofuscin.
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